General Information of the Compound
Compound ID
CP0519739
Compound Name
(S)-N-((S)-1-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-1-((S)-3-(4-hydroxyphenyl)-2-(4-oxo-4-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-ylamino)butanamido)propanoyl)pyrrolidine-2-carboxamide
    Show/Hide
Structure
Formula
C44H53N7O12
Molecular Weight
871.945
Canonical SMILES
NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
    Show/Hide
InChI
InChI=1S/C44H53N7O12/c45-40(59)30(19-24-7-2-1-3-8-24)48-41(60)31(21-26-22-46-29-10-5-4-9-28(26)29)49-42(61)33-11-6-18-51(33)44(62)32(20-25-12-14-27(53)15-13-25)47-35(54)16-17-36(55)50-43-39(58)38(57)37(56)34(23-52)63-43/h1-5,7-10,12-15,22,30-34,37-39,43,46,52-53,56-58H,6,11,16-21,23H2,(H2,45,59)(H,47,54)(H,48,60)(H,49,61)(H,50,55)/t30-,31-,32-,33-,34+,37+,38-,39+,43+/m0/s1
    Show/Hide
InChIKey
MHIFIDPWHSQGON-ZKZHZIGFSA-N
Physicochemical Property
logP
-1.4716
Rotatable Bonds
18
Heavy Atom Count
63
Polar Areas
305.97
Hydrogen Bond Donor Count
11
Hydrogen Bond Acceptor Count
12
Complexity
63

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44586711
ChEMBL ID
CHEMBL499141
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000004 SH-SY5Y Homo sapiens (Human)  1
1
Ki = 115 nM
   TI
   LI
   LO
   TS